Brian K Kaspar Selected Research

Brian K Kaspar Research Topics

Disease

9	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2018 - 05/2005
6	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2019 - 01/2009
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2009
4	Disease Progression 11/2019 - 08/2003
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2017 - 10/2012
3	Paralysis (Palsy) 03/2015 - 05/2005
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 11/2019 - 02/2015
2	Neuroinflammatory Diseases 11/2019 - 02/2015
2	Inflammation (Inflammations) 12/2015 - 03/2014
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2015 - 10/2011
2	Rett Syndrome (Rett's Disorder) 08/2013 - 06/2011
2	Nervous System Diseases (Neurological Disorders) 08/2013 - 11/2012
1	Hypertrophy 01/2021
1	Atrophy 11/2019
1	Motor Neuron Disease (Primary Lateral Sclerosis) 11/2017
1	Inclusion Body Myositis 01/2017
1	Spinal muscular atrophy with respiratory distress 1 03/2015
1	Muscle Weakness 03/2015
1	Demyelinating Diseases (Demyelinating Disease) 01/2015
1	Amyloid Plaque 02/2014
1	Alzheimer Disease (Alzheimer's Disease) 02/2014
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 10/2012
1	Autism Spectrum Disorder 06/2011
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2010
1	Muscular Diseases (Myopathy) 11/2009
1	Infections 02/2006
1	Hypersensitivity (Allergy) 06/2003
1	Pain (Aches) 06/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2019 - 05/2005
3	FollistatinIBA 01/2021 - 01/2015
3	Superoxide Dismutase-1IBA 09/2018 - 12/2013
3	Transcription Factors (Transcription Factor)IBA 12/2015 - 06/2011
2	Small Interfering RNA (siRNA)IBA 01/2020 - 05/2005
2	Superoxide DismutaseIBA 04/2015 - 05/2005
2	Biomarkers (Surrogate Marker)IBA 03/2015 - 01/2014
2	Nerve Growth Factors (Neurotrophins)IBA 02/2015 - 08/2010
2	Methyl-CpG-Binding Protein 2IBA 08/2013 - 06/2011
2	Pharmaceutical PreparationsIBA 11/2012 - 05/2005
2	Insulin (Novolin)FDA Link 06/2008 - 05/2005
1	MyostatinIBA 01/2021
1	Ataxin-3IBA 11/2019
1	Glutamine (L-Glutamine)FDA Link 11/2019
1	Messenger RNA (mRNA)IBA 11/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 11/2019
1	ZolgensmaIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Liver X ReceptorsIBA 12/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2015
1	Neuroprotective AgentsIBA 02/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	DystrophinIBA 01/2015
1	NF-kappa B (NF-kB)IBA 03/2014
1	Peptides (Polypeptides)IBA 02/2014
1	SDPM1 peptideIBA 02/2014
1	Amyloid (Amyloid Fibrils)IBA 02/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2012
1	MorpholinosIBA 10/2012
1	Sarcoglycans (beta Sarcoglycan)IBA 10/2012
1	CorticosteroneIBA 12/2011
1	GlucocorticoidsIBA 12/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2008
1	Neutralizing AntibodiesIBA 02/2006
1	Insulin-Like PeptidesIBA 08/2003
1	Formaldehyde (Formol)FDA Link 06/2003
1	NMDA receptor A1IBA 06/2003
1	Cre recombinaseIBA 06/2003
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2003
1	N-Methylaspartate (NMDA)IBA 06/2003

Therapy/Procedure

14	Therapeutics 11/2019 - 05/2005
2	Intramuscular Injections 01/2017 - 05/2005
2	Transplantation 02/2015 - 03/2013
1	Artificial Respiration (Mechanical Ventilation) 11/2017